课题基金 / 基金详情

项目摘要

项目成果

ROSE HOOD的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To address the paucity of effective treatments for disorders of the nervous system, the NIH has established the Blueprint Neurotherapeutics Network (http://neuroscienceblueprint.nih.gov/bpdrugs/index.htm). This program intends to develop drugs successfully through clinical Phase I and facilitate industry partnerships for their full development. The long-term goal of this grand challenge is to produce at least one novel and effective medication for a disorder of the nervous system that is currently poorly treated or untreated. The NIH Blueprint Neurotherapeutics Network is establishing a ¿virtual pharma¿ network of contract service providers and consultants with extensive industry experience to enable drug development in the NIH neuroscience research community. The Network offers neuroscience researchers access to a full range of industry-style drug development services and expertise, including medicinal chemistry, IND-enabling studies, and Phase 1 clinical trial infrastructure. The Pharmacology and Toxicology for Neurotherapeutics Program (PTNP) contracts support all preclinical pharmacology and toxicology testing needed to inform lead optimization and the selection of a clinical candidate, and comprehensive studies needed for an Investigational New Drug (IND) application for the FDA to allow for clinical evaluation of New Chemical Entities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IGF::OT::IGF "Rodent Pharmacokinetic and Brain Level Determination"
  • 批准号:
    8759147
  • 项目类别:
  • 资助金额:
    $9.99万
  • 财政年份:
    2013
  • 负责人:
    ROSE HOOD
  • 依托单位:
IGF::OT::IGF "Pharmacology and Toxicology for Neurotherapeutics (PTNP)"
  • 批准号:
    8759765
  • 项目类别:
  • 资助金额:
    $9.92万
  • 财政年份:
    2013
  • 负责人:
    ROSE HOOD
  • 依托单位:
Pharmacology and Neurotherapeutics Program (PTNP)
  • 批准号:
    8655003
  • 项目类别:
  • 资助金额:
    $20.48万
  • 财政年份:
    2013
  • 负责人:
    ROSE HOOD
  • 依托单位:
Development and Maintenance of a Multigenotypic Aged Rat Colony
海外基金